Lipoprotein Biomarkers and Risk of Cardiovascular Disease: A Laboratory Medicine Best Practices (LMBP) Systematic Review (Q64125281)

1

0 references

Salma M A Musaad

2

0 references

Stephanie S Buehler

4

0 references

Sonya Strider

5

0 references

James H Derzon

6

0 references

Hubert W Vesper

7

0 references

Anne Ranne

8

0 references

Colleen S Shaw

9

0 references

Robert H Christenson

Elevated ApoB serum levels strongly predict early cardiovascular events

10

0 references

language of work or name

English

0 references

publication date

1 September 2016

0 references

volume

1

0 references

page(s)

214-229

0 references

issue

2

0 references

cites work

1 reference

12 December 2020

Laboratory approaches for predicting and managing the risk of cardiovascular disease: postanalytical opportunities of lipid and lipoprotein testing

1 reference

12 December 2020

Oxidised LDL, HDL cholesterol, LDL cholesterol levels in patients of coronary artery disease

1 reference

12 December 2020

Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.

1 reference

12 December 2020

The importance of non-HDL cholesterol reporting in lipid management

1 reference

12 December 2020

Cardiovascular risk factors in elderly normolipidemic acute myocardial infarct patients--a case controlled study from India.

1 reference

12 December 2020

Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.

1 reference

12 December 2020

Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines

1 reference

12 December 2020

Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events

1 reference

12 December 2020

2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult

1 reference

12 December 2020

Lipid assessment, metabolic syndrome and coronary heart disease risk

1 reference

12 December 2020

Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review

1 reference

12 December 2020

Prevalence of Obesity Among Adults and Youth: United States, 2011-2014.

1 reference

12 December 2020

Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study.

1 reference

12 December 2020

Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices

1 reference

12 December 2020

Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS).

1 reference

12 December 2020

Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update

1 reference

12 December 2020

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

12 December 2020

Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels

1 reference

12 December 2020

Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men

1 reference

12 December 2020

1 reference

12 December 2020

Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker

1 reference

12 December 2020

Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures

1 reference

12 December 2020

Vascular risk calculators: essential but flawed clinical tools?

1 reference

12 December 2020

Strategies for vascular disease prevention: the role of lipids and related markers including apolipoproteins, low-density lipoproteins (LDL)-particle size, high sensitivity C-reactive protein (hs-CRP), lipoprotein-associated phospholipase A2 (Lp-PLA

1 reference

12 December 2020

Low-density lipoprotein-lowering strategies: target versus maximalist versus population percentile

1 reference

12 December 2020

The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk

1 reference

12 December 2020

Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study

1 reference

12 December 2020

The apolipoprotein B/AI ratio and the metabolic syndrome independently predict risk for myocardial infarction in middle-aged men.

1 reference

12 December 2020

Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study

1 reference

12 December 2020

Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes

1 reference

12 December 2020

Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists.

1 reference

12 December 2020

Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population

1 reference

12 December 2020

Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: tests for silent and inducible ischemia: Writing Group II

1 reference

12 December 2020

Use of lipoprotein particle measures for assessing coronary heart disease risk post-American Heart Association/American College of Cardiology guidelines: the Multi-Ethnic Study of Atherosclerosis.

1 reference

12 December 2020

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted

1 reference

12 December 2020

Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men.

1 reference

12 December 2020

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association

1 reference

12 December 2020

Novel metabolic risk factors for heart failure

1 reference

12 December 2020

The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology

1 reference

12 December 2020

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

12 December 2020

Apolipoprotein B/A-I and total cholesterol/high-density lipoprotein cholesterol ratios both predict cardiovascular events in the general population independently of nonlipid risk factors, albuminuria and C-reactive protein.

1 reference

12 December 2020

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.

1 reference

12 December 2020

Censoring in clinical trials: review of survival analysis techniques

1 reference

12 December 2020

Common and rare alleles in apolipoprotein B contribute to plasma levels of low-density lipoprotein cholesterol in the general population

1 reference

12 December 2020

Discordance analysis of apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study

1 reference

12 December 2020

Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study

1 reference

12 December 2020

The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence

1 reference

12 December 2020

Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk

1 reference

12 December 2020

Clinical Utility of Different Lipid Measures for Prediction of Coronary Heart Disease in Men and Women

1 reference

12 December 2020

Non-high-density lipoprotein cholesterol versus apolipoprotein B in cardiovascular risk stratification: do the math.

1 reference

12 December 2020

Relative importance of different lipid risk factors for the development of myocardial infarction at a very young age (≤ 40 years of age).

1 reference

12 December 2020

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

1 reference

12 December 2020

Laboratory medicine best practices: systematic evidence review and evaluation methods for quality improvement

1 reference

12 December 2020

Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI).

1 reference

12 December 2020

Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study

1 reference

12 December 2020

A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk

1 reference

12 December 2020

Apolipoprotein measurements: is more widespread use clinically indicated?

1 reference

12 December 2020